Persistent or Recurrent Diabetic Macular Edema after Fluocinolone Acetonide 0.19 mg Implant: risk factors and management.
Sign Up to like & getrecommendations! Published in 2020 at "American journal of ophthalmology"
DOI: 10.1016/j.ajo.2020.03.016
Abstract: PURPOSE To investigate baseline characteristics of patients undergoing additional anti-vascular endothelial growth factor (VEGF) injections for residual or recurrent diabetic macular edema (DME) in the first year after 0.19 mg fluocinolone acetonide (FAc) implant. DESIGN… read more here.
Keywords: anti vegf; risk; recurrent diabetic; dme ... See more keywords